These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4971 related items for PubMed ID: 17827036

  • 21. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM.
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [Abstract] [Full Text] [Related]

  • 22. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ, Thompson JS, Jennings CD, Brown SA.
    Transplantation; 1995 Oct 27; 60(8):821-7. PubMed ID: 7482742
    [Abstract] [Full Text] [Related]

  • 23. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.
    Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [Abstract] [Full Text] [Related]

  • 24. A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice.
    De Ruysscher D, Sobis H, Vandeputte M, Waer M.
    J Immunol; 1991 Jun 15; 146(12):4065-70. PubMed ID: 1828259
    [Abstract] [Full Text] [Related]

  • 25. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
    Bornhäuser M, Thiede C, Platzbecker U, Jenke A, Helwig A, Plettig R, Freiberg-Richter J, Röllig C, Geissler G, Lutterbeck K, Oelschlagel U, Ehninger G.
    Clin Cancer Res; 2001 Aug 15; 7(8):2254-62. PubMed ID: 11489799
    [Abstract] [Full Text] [Related]

  • 26. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
    Wu B, Guo K, Song Z, Yan D, Yang Y, Xiao L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr 15; 23(4):194-7. PubMed ID: 12133456
    [Abstract] [Full Text] [Related]

  • 27. Induction of tolerance in organ recipients by hematopoietic stem cell transplantation.
    Ophir E, Reisner Y.
    Int Immunopharmacol; 2009 Jun 15; 9(6):694-700. PubMed ID: 19150657
    [Abstract] [Full Text] [Related]

  • 28. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2008 Dec 15; 36(12):1750-9. PubMed ID: 18809241
    [Abstract] [Full Text] [Related]

  • 29. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L, Glass B, Zeis M, Dreger P, Steinmann J, Löffler H, Schmitz N.
    Exp Hematol; 1998 Feb 15; 26(2):93-9. PubMed ID: 9472798
    [Abstract] [Full Text] [Related]

  • 30. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, Vanbellinghen JF, Hafraoui K, Lejeune M, Gothot A, Fillet G, Beguin Y.
    Biol Blood Marrow Transplant; 2010 Jun 15; 16(6):838-47. PubMed ID: 20109568
    [Abstract] [Full Text] [Related]

  • 31. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E, Weiss L, Kasir J, Zeira M, Slavin S, Shapira MY.
    Bone Marrow Transplant; 2006 Sep 15; 38(5):359-64. PubMed ID: 16862165
    [Abstract] [Full Text] [Related]

  • 32. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
    Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, Quinlan D, Stewart D.
    Biol Blood Marrow Transplant; 2007 Mar 15; 13(3):299-306. PubMed ID: 17317583
    [Abstract] [Full Text] [Related]

  • 33. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
    Chen GH, Wu DP, Sun AN, Yang MZ, Wang Y, Tang XW, Chang HR, Feng YF, Zhu ZL.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug 15; 29(8):526-30. PubMed ID: 19112915
    [Abstract] [Full Text] [Related]

  • 34. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
    Gorantla VS, Prabhune KA, Perez-Abadia G, Ildstad ST, Maldonado C, Orhun HI, Majzoub RK, Francois CG, Kakoulidis TP, Brouha PC, Anderson GL, Pidwell DJ, Breidenbach WC, Barker JH.
    Transplantation; 2003 Apr 15; 75(7):922-32. PubMed ID: 12698075
    [Abstract] [Full Text] [Related]

  • 35. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation.
    Seidel MG, Fritsch G, Matthes-Martin S, Lawitschka A, Lion T, Pötschger U, Rosenmayr A, Fischer G, Gadner H, Peters C.
    Haematologica; 2005 Oct 15; 90(10):1405-14. PubMed ID: 16219578
    [Abstract] [Full Text] [Related]

  • 36. [Influence of methylprednisolone on cell component of donor graft and on H-2 haploidentical hematopoietic stem cell transplantation in mice].
    Liu JM, Li YF, Ding BH, Xuan HB, Zhang LS.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb 15; 30(2):87-91. PubMed ID: 19563017
    [Abstract] [Full Text] [Related]

  • 37. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
    Lan F, Zeng D, Higuchi M, Higgins JP, Strober S.
    Biol Blood Marrow Transplant; 2003 Jun 15; 9(6):355-63. PubMed ID: 12813443
    [Abstract] [Full Text] [Related]

  • 38. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.
    Biol Blood Marrow Transplant; 2008 May 15; 14(5):568-75. PubMed ID: 18410899
    [Abstract] [Full Text] [Related]

  • 39. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
    Soiffer RJ, Mauch P, Tarbell NJ, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Murrey CI, Coral F, Bosserman L.
    Bone Marrow Transplant; 1991 Jan 15; 7(1):23-33. PubMed ID: 2043874
    [Abstract] [Full Text] [Related]

  • 40. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
    Ruggeri L, Mancusi A, Burchielli E, Capanni M, Carotti A, Aloisi T, Aversa F, Martelli MF, Velardi A.
    Blood Cells Mol Dis; 2008 Jan 15; 40(1):84-90. PubMed ID: 17964828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 249.